Technical Description
The invention presents a 3D-printed hydrogel implant contains engineered cells to secrete IGF-1, potentially reversing Type 1 Diabetes long-term.
Problems Addressed
- Poor Stability
- Low Viscosity
- Prone to Immune Rejection
- Health Complications
Tech Features
- 3D-printed Implantable Hydrogel
- Improved Vascularization
- Islet-mediated Insulin Secretion
- Natural Polymer Based System
- Long-term Effect
Target Audience
- Pharmaceutical Industry
- Diagnostic Centres
- Healthcare
- Diabetes Care Units
Tech ID: P27-2016 TRL 5 Patent Status: Published Available For Exclusive and Non-exclusive License
